Microba Life Sciences Ltd Cash Flow-to-Debt Ratio
Microba Life Sciences Ltd cash flow-to-debt ratio. Microba Life Sciences Ltd (MAP) has a Cash Flow-to-Debt Ratio of -0.46x as of December 2025, meaning its operating cash flow of AU$-5.70 Million could theoretically repay 0% of its total liabilities (AU$12.27 Million) in one year. See Microba Life Sciences Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Microba Life Sciences Ltd (2018–2024)
Cash flow-to-debt ratio of Microba Life Sciences Ltd from 2018 to 2024. Historical debt coverage capacity for Microba Life Sciences Ltd across 7 annual periods. Also explore Microba Life Sciences Ltd (MAP) net asset momentum to track the company's year-over-year net asset growth rate.
Microba Life Sciences Ltd Cash Flow-to-Debt Ratio by Year (2018–2024)
Microba Life Sciences Ltd cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for Microba Life Sciences Ltd. For the full cash flow conversion analysis, see Microba Life Sciences Ltd (MAP) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.80x | AU$-12.01 Million | AU$14.94 Million | ▲ +13.1% |
| 2023 | -0.93x | AU$-15.57 Million | AU$16.82 Million | ▲ +38.6% |
| 2022 | -1.51x | AU$-12.39 Million | AU$8.23 Million | ▲ +14.3% |
| 2021 | -1.76x | AU$-10.45 Million | AU$5.94 Million | ▲ +13.1% |
| 2020 | -2.02x | AU$-7.18 Million | AU$3.55 Million | ▼ -45.2% |
| 2019 | -1.39x | AU$-4.32 Million | AU$3.10 Million | ▲ +44.8% |
| 2018 | -2.52x | AU$-3.62 Million | AU$1.43 Million | — |